SV

Street Verdict

Analyst Scorecard

NH · NSE

Narayana Hrudayalaya Ltd.

₹1,943.7

+3.77% (+₹70.6)

Prev. close

₹1,873.1

Volume

7,84,702

Delivery %

29.1%

As of

20 Nov 2026

Price history

₹1,943.7+₹140.7 (+7.80%) · 3M
18 Aug 2026 → 20 Nov 2026
1,6501,7001,7501,8001,8501,90018 Aug09 Sept06 Oct29 Oct20 Nov
Daily closes · updates after each session

Analyst sentiment

No analyst stances in this range

0 analyst stances · last 90 days · one per analyst

Try a wider range.

Explore by date range →

Analyst opinions

CallAnalystInstrumentVerdictActions
Market commentary · 6 · levels, conditionals, previews, macro & hedged views — context, not graded
CallAnalystInstrumentVerdictActions

Fundamentals

About Narayana Hrudayalaya Ltd.

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, uro oncology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

Details

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Dr. Emmanuel Rupert

Headquarters

Bengaluru

Employees

11,234

Key stats

Market cap

₹39,401.37 Cr

P/E ratio (TTM)

44.2

Dividend yield

0.23%

EPS (TTM)

₹43.92

Beta (1Y · daily vs NIFTY 50)

0.85

Beta (5Y · monthly vs NIFTY 50)

0.94

Shares float

6.60 Cr

EPS · quarter ended Sept 2026

₹14.82

Financial Performance

01 · Financials

0 Cr2000 Cr4000 Cr6000 Cr8000 Cr₹0%5%10%15%20%FY22FY23FY24FY25FY26
RevenueNet incomeEBITDANet income ÷ revenue

02 · Earnings Per Share (EPS)

-2002040₹FY21FY22FY23FY24FY25FY26

03 · Dividend Profile

0246₹0%50%100%150%11 Mar 2022 Aug 2207 Jul 2302 Aug 2401 Aug 2517 Jul 26
Dividend (₹/share)Annualised yieldAnnual dividend growth (FY)

Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: NSE corporate actions.

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based

-50%0%50%100%FY21FY22FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

0 Cr5000 Cr10000 Cr15000 Cr₹0×0.5×1×1.5×FY21FY22FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

0 Cr5000 Cr10000 Cr15000 Cr₹FY21FY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

-5000 Cr0 Cr5000 Cr10000 Cr₹FY21FY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹2,582.35 Cr₹3,701.32 Cr₹4,524.77 Cr₹5,018.25 Cr₹5,482.98 Cr₹7,896.04 Cr
EBITDA
₹203.44 Cr₹679.56 Cr₹1,031.08 Cr₹1,227.55 Cr₹1,360.06 Cr₹1,665.94 Cr
₹-14.30 Cr₹341.93 Cr₹606.25 Cr₹789.26 Cr₹790.16 Cr₹805.60 Cr
Diluted EPS
₹-0.7₹16.84₹29.85₹38.86₹38.9₹39.67

EBITDA for Mar 2021 could not be checked against the company's own annual report: this page shows ₹203.44 Cr while the annual report gives ₹210.28 Cr (3.4% apart). That disagreement leaves the whole cross-check inconclusive, so EBITDA for Mar 2020 (the annual report alone gives ₹446.67 Cr) is left blank here too, rather than shown from only one of the two sources.

09 · Balance Sheet

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹2,770.02 Cr₹3,130.53 Cr₹4,162.09 Cr₹5,624.58 Cr₹7,265.03 Cr₹12,474.40 Cr
₹825.64 Cr₹723.42 Cr₹884.17 Cr₹1,626.69 Cr₹2,428.37 Cr₹5,857.50 Cr
Stockholders' equity
₹1,120.28 Cr₹1,488.64 Cr₹2,131.38 Cr₹2,883.68 Cr₹3,626.36 Cr₹4,537.26 Cr

Trade receivables, CWIP, Others, Long-term debt, Current (short-term) debt have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY21FY22FY23FY24FY25FY26
₹309.05 Cr₹485.02 Cr₹1,084.56 Cr₹1,066.60 Cr₹990.08 Cr₹1,618.46 Cr
Investing cash flow
₹-112.99 Cr₹-266.91 Cr₹-1,174.10 Cr₹-1,457.94 Cr₹-1,317.12 Cr₹-3,699.90 Cr
₹-198.43 Cr₹-158.95 Cr₹87.74 Cr₹488.45 Cr₹544.31 Cr₹2,342.93 Cr
Capital expenditure
₹-70.10 Cr₹-250.68 Cr₹-522.04 Cr₹-970.61 Cr₹-1,073.76 Cr₹-874.94 Cr
End cash position
₹89.51 Cr₹148.53 Cr₹144.59 Cr₹241.74 Cr₹447.16 Cr₹760.57 Cr

Debt issued, Debt repaid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

11 · Shareholding Pattern

NSE, quarterly

Line itemSep 21–Mar 22(3Q)Jun 22–Sep 22(2Q)Dec 22–Jun 23(3Q)Sep 23–Sep 25(9Q)Dec 25–Jun 26(3Q)
Promoter63.85%63.85%63.85%63.85%63.27%
Public35.45%35.46%35.52%35.53%36.11%
Employee trusts0.70%0.69%0.63%0.62%0.62%

Source: NSE quarterly shareholding-pattern filings, collapsed to periods where the reported percentages held steady — a column spanning several quarters means no change was filed across them. No FII/DII sub-split available from this source — Public includes all non-promoter, non-employee-trust holders.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.25 L Cr₹1,769.938.85.0913.7%0.06+11.9%+3.7%
Divi's Laboratories Limited₹2.66 L Cr₹10,037.590.815.8515.3%0.00+12.3%+47.5%
Torrent Pharmaceuticals Limited₹1.79 L Cr₹4,738.579.421.3125.8%1.79+21.5%+32.5%
Laurus Labs Limited₹1.27 L Cr₹2,34894.823.9416.8%0.48+22.0%+146.2%
Apollo Hospitals Enterprise Limited₹1.23 L Cr₹8,599.558.812.9520.5%0.90+15.7%+10.1%
Zydus Lifesciences Limited₹1.19 L Cr₹1,188.126.74.4018.6%0.46+18.4%+22.3%
Lenskart Solutions Limited₹1.16 L Cr₹689.7181.413.305.6%0.35+35.4%—
Dr. Reddy's Laboratories Limited₹1.14 L Cr₹1,37440.63.0211.4%0.21+3.2%+14.5%
Cipla Limited₹1.13 L Cr₹1,40238.93.2711.3%0.02+2.1%-6.7%
Mankind Pharma Limited₹1.03 L Cr₹2,47545.96.3111.7%0.39+17.0%+3.1%
Aurobindo Pharma Limited₹98,101.93 Cr₹1,70526.62.599.2%0.21+6.4%+48.4%
Narayana Hrudayalaya Ltd.₹38,814.41 Cr₹1,931.544.98.5517.8%1.29+43.8%+5.5%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

NH

BSE Hospitals index soars 3%; Apollo, Max, Narayana Hrudayalaya surge 5%

Business Standard · 3 days ago

NH

Narayana Hrudayalaya NH Q2 FY27 Earnings Call Key Takeaways

Kalkine India · 15 days ago